Conflicting data exist regarding the relationship between hepatitis C virus genotype 1 and hepatic steatosis as well as the latter's role in the progression of fibrosis and treatment response. We assessed factors associated with hepatic steatosis in genotype 1 chronic hepatitis C and the impact of h
Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines
β Scribed by Ian Homer Y. Cua; Jason M. Hui; Priyanka Bandara; James G. Kench; Geoffrey C. Farrell; Geoffrey W. McCaughan; Jacob George
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 126 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
The role of tumor necrosis factor alpha, interleukin 6, leptin, and adiponectin in the pathogenesis of hepatitis C virus (HCV)-associated insulin resistance (IR) remains controversial. We tested the hypothesis that these adipocytokines contribute to chronic HCV-associated IR and liver injury by first comparing their serum levels and homeostasis model assessment of insulin resistance (HOMA-IR) in 154 untreated, non-diabetic, HCV-infected male subjects with fibrosis stage 0-2, to that in 75 healthy volunteers matched for age, body mass index (BMI), and waist-hip ratio (WHR). We next examined whether the adipocytokine levels were associated with the extent of hepatic steatosis, portal/periportal inflammation and fibrosis in our total cohort of 240 HCV-infected male subjects. Significantly higher levels of HOMA-IR (2.12 versus 1.63, P = 0.01), TNFalpha (1.28 versus 0.60 pg/ml, P < 0.001) and IL6 (2.42 versus 1.15 pg/ml, P = 0.001) were noted in the HCV cohort compared with healthy controls respectively, but there were no significant differences in leptin and adiponectin concentrations. By multiple linear regression, independent predictors of HOMA-IR included the body mass index, and the serum levels of leptin (positive correlation) and adiponectin (negative correlation), but not that of TNFalpha and IL6. Only TNFalpha levels were correlated with the extent of histological injury (portal/periportal inflammation, P = 0.02).
Conclusion:
Whereas leptin and adiponectin contribute to ir, none of the adipocytokines accounted for the elevated ir in hcv-infected subjects. the adipocytokines were not associated with histological features of chronic hcv infection except for tnfalpha which correlated with portal/periportal inflammation. hcv-associated ir is most likely an adipocytokine-independent effect of the virus to modulate insulin sensitivity.
π SIMILAR VOLUMES
In an earlier study, we observed only a weak association between plasma insulin (nonspecific assay) and leptin in South Asian Indians. This was in contrast to the observations in many other ethnic groups. With the availability of measurements of specific insulin (SI) and proinsulin (PI) in the same
Hepatitis C virus (HCV) genotypes help to tailor the treatment response, but their influence on the disease severity and association with hepatic steatosis is not well understood. The prevalence of HCV genotypes and their correlation with the histopathological severity of liver disease and steatosis
firmed on pathologic review. From these specimens DNA was isolated. Tumor samples were analyzed for EBV and HIV using a polymerase chain reaction (PCR) 1 Section of Surgical Oncology, Louisiana State technique followed by gel electrophoresis and Southern blot analysis.
## Abstract Chronic hepatitis C virus (HCV) and hepatitis B virus (HBV) infection is accompanied by inflammation and fibrosis eventually leading to cirrhosis. The chemokine CXCL12 is involved in chronic inflammatory conditions. The role of the CXCL12/CXCR4 pathway in HCVβ and HBVβassociated liver i
## Abstract Hepatitis C virus (HCV) RNA persistence in the liver has been described even after apparent resolution of HCV infection. Because Tβcell reactivity plays a role in recovery from HCV infection, virusβspecific Tβcell responses were investigated in apparently recovered individuals in whom h